Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Allied Energy, Inc (OTC: AGGI) wins majority stake in WeLife Technology Corp

LOS ANGELES, CA, Feb 26, 2022 - (ACN Newswire) - Allied Energy, Inc (OTC: AGGI) has won control of a majority stake in WeLife Technology Corp via a tender for the company's shares, whose acceptance period closed on February 25, 2022.

WeLife Technology Corp is a biotech company with at least five products globally generating millions in sales. Its chief scientist is Dr Michael Borkin, who has developed an international reputation for his extensive research and clinical experience in the areas of life extension and anti-aging.

Dr Borkin's emphasis on endocrine and neuro-transmitter regulation led to the development of unique non-invasive diagnostic and treatment protocols that dramatically increases both patient acceptance and treatment success rates.

With more than 70 supplements formulated by Dr Borkin marketed worldwide, and having an unparalleled reputation, Dr Borkin sets a Gold Standard within the Nutraceutical Industry, and continues to innovate new technologies and produce advanced protocols to slow and reverse the Ageing Process.

Dr Michael Borkin
Co-Founder, Sabre Sciences and Endoscreen Laboratories
Chief Scientist, WeLife Technology Corporation

Considered the "Father of Naturopathic Endocrinology", Dr. Borkin was responsible for establishing the board specialty and authored the first National Board in Endocrinology for the American Naturopathic Medical Certification & Accreditation Board in Washington, DC.

In 1986 he began development of a transdermal delivery system designed to deliver hormones and nutraceuticals through the skin. In 1998 he co-founded Sabre Sciences and Endoscreen Laboratories to prove efficacy for this novel delivery system.

He was appointed president of the California State Naturopathic Medical Association in 1993 and served until 1997. In 2002 Dr. Borkin was inducted into the Alternative Medicine Hall of Fame, making him the youngest inductee ever so honored.

Dr. Borkin's patients have included Heads of State, Religious leaders, and Celebrities and Athletic Icons. Now dedicated full time to research and teaching, he has more than 36 years of clinical experience, which he shares with medical researchers around the globe. He currently has teaching facilities in San Diego, California; Coronado, Panama; St. Petersburg, Russia and Nice, France.

About WeLife Technology Corp
WeLife Technology Corp., establish in 2018, is a biotechnology and human health product development and marketing company. For more information, visit https://welifeus.com/home/index.

About Allied Energy, Inc
Allied Energy, Inc. (OTCMKTS: AGGI) operates as an independent oil and natural gas exploration and development company operating in the continental United States. Please visit https://www.alliedag.com.

Source: WeLife Tech Corp

Copyright 2022 ACN Newswire . All rights reserved.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.